API Suppliers
US DMFs Filed
0
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
0
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
97
PharmaCompass offers a list of Alfacalcidol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Alfacalcidol manufacturer or Alfacalcidol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Alfacalcidol manufacturer or Alfacalcidol supplier.
PharmaCompass also assists you with knowing the Alfacalcidol API Price utilized in the formulation of products. Alfacalcidol API Price is not always fixed or binding as the Alfacalcidol Price is obtained through a variety of data sources. The Alfacalcidol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer, including repackagers and relabelers. The FDA regulates 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer supplier is an individual or a company that provides 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer active pharmaceutical ingredient (API) or 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer finished formulations upon request. The 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer suppliers may include 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer API manufacturers, exporters, distributors and traders.
click here to find a list of 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer Drug Master File in Japan (1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer JDMF) empowers 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer JDMF during the approval evaluation for pharmaceutical products. At the time of 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer Drug Master File in Korea (1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer. The MFDS reviews the 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer KDMF as part of the drug registration process and uses the information provided in the 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer KDMF to evaluate the safety and efficacy of the drug.
After submitting a 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer suppliers with KDMF on PharmaCompass.
A 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer CEP of the European Pharmacopoeia monograph is often referred to as a 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer Certificate of Suitability (COS). The purpose of a 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer to their clients by showing that a 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer CEP has been issued for it. The manufacturer submits a 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer CEP (COS) as part of the market authorization procedure, and it takes on the role of a 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer CEP holder for the record. Additionally, the data presented in the 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer DMF.
A 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer suppliers with CEP (COS) on PharmaCompass.
A 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer written confirmation (1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer WC) is an official document issued by a regulatory agency to a 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer manufacturer, verifying that the manufacturing facility of a 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer APIs or 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer finished pharmaceutical products to another nation, regulatory agencies frequently require a 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer WC (written confirmation) as part of the regulatory process.
click here to find a list of 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer suppliers with Written Confirmation (WC) on PharmaCompass.
1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer GMP manufacturer or 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer GMP API supplier for your needs.
A 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer CoA (Certificate of Analysis) is a formal document that attests to 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer's compliance with 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer specifications and serves as a tool for batch-level quality control.
1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer CoA mostly includes findings from lab analyses of a specific batch. For each 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer may be tested according to a variety of international standards, such as European Pharmacopoeia (1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer EP), 1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer USP).